Low-Dose Transdermal Patches With High Drug Release

Patent No. EP2613772 (titled "Low-Dose Transdermal Patches With High Drug Release") was filed by Bayer on Sep 5, 2011. The application was issued on Dec 14, 2016.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Company	Opposition Date	Representative
LTS LOHMANN THERAPIE SYSTEM GMBH	Sep 14, 2017	PLATE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

Date
Description

Get instant alerts for new documents

Oct 11, 2018
Communication to the parties concerning the termination of the opposition proceedings (opponent)
Oct 11, 2018
Communication to the parties concerning the termination of the opposition proceedings (proprietor)
Oct 8, 2018
Termination of the opposition proceedings with revocation of patent
Jul 30, 2018
Advice of delivery
Jul 18, 2018
Advice of delivery
Jul 5, 2018
(Electronic) Receipt
Jul 5, 2018
Advice of delivery
Jul 5, 2018
Letter accompanying subsequently filed items
Jul 2, 2018
Advice of delivery
Jun 26, 2018
Acknowledgement of a document
Jun 26, 2018
Acknowledgement of a document
Jun 26, 2018
Decision of the Opposition Division and instruction
Jun 26, 2018
Decision revoking the European patent
Jun 26, 2018
Grounds for the decision (Annex) - opposition
Jun 26, 2018
Internal form - Opposition/addressees
Feb 2, 2018
Confirmation of revocation of automatic debit order
Oct 23, 2017
Communication of a notice of opposition and request to file observations
Oct 23, 2017
Notice of further oppositions to opponent(s)
Sep 22, 2017
Communication of a notice of opposition - first information to patent proprietor
Sep 14, 2017
(Electronic) Receipt
Sep 14, 2017
Non-patent literature cited during the opposition procedure
Sep 14, 2017
Notice of opposition
Sep 14, 2017
Notice of opposition
Sep 14, 2017
Patent document cited during the opposition procedure
Sep 14, 2017
Patent document cited during the opposition procedure
Dec 15, 2016
Transmission of the certificate for a European patent pursuant to Rule 74 EPC
Nov 17, 2016
Decision to grant a European patent
Nov 3, 2016
(Electronic) Receipt
Nov 3, 2016
French translation of claims
Nov 3, 2016
German translation of the claims
Nov 3, 2016
Letter accompanying subsequently filed items
Jul 14, 2016
Bibliographic data of the European patent application
Jul 14, 2016
Communication about intention to grant a European patent
Jul 14, 2016
Intention to grant (signatures)
Jul 14, 2016
Text intended for grant (clean copy)
Jul 14, 2016
Text intended for grant (version for approval)
May 24, 2016
(Electronic) Receipt
May 24, 2016
Amended claims with annotations
May 24, 2016
Claims
May 24, 2016
Letter accompanying subsequently filed items
May 24, 2016
Reply to communication from the Examining Division
May 4, 2016
Annex to a communication
May 4, 2016
Annex to the communication
May 4, 2016
Consultation by telephone/in person
May 4, 2016
Result of consultation by telephone/in person
Jan 18, 2016
Annex to the communication
Jan 18, 2016
Communication from the Examining Division
Jun 11, 2015
CDS Clean up - amended data concerning the representative of the applicant (Association)
Apr 14, 2015
(Electronic) Receipt
Apr 14, 2015
Amended claims with annotations
Apr 14, 2015
Claims
Apr 14, 2015
Reply to communication from the Examining Division
Dec 22, 2014
Annex to the communication
Dec 22, 2014
Communication from the Examining Division
Dec 12, 2014
Examination started
Nov 21, 2013
(Electronic) Receipt
Nov 21, 2013
Amended claims filed after receipt of (European) search report
Nov 21, 2013
Amended claims with annotations
Nov 21, 2013
Amendments received before examination
Nov 21, 2013
Letter accompanying subsequently filed items
Jun 19, 2013
Notification on forthcoming publication of bibliographic data
May 13, 2013
Communication concerning correction of deficiencies in written opinion/amendment of application/payment of claims fee
May 3, 2013
Communication to designated inventor
May 3, 2013
Communication to designated inventor
May 3, 2013
Communication to designated inventor
Mar 27, 2013
Copy of the international preliminary report on patentability
Mar 22, 2013
(Electronic) Receipt
Mar 22, 2013
Annex
Mar 22, 2013
Request for entry into the European phase
Jan 18, 2013
Information on entry into European phase
Nov 30, 2012
CDS Clean up - amended data concerning the representative of the applicant (Association)
Nov 29, 2012
Submission concerning representation
Oct 10, 2012
Notification of the recording of a change
Oct 10, 2012
Notification of the recording of a change
Aug 2, 2012
Copy of the international search report
Aug 2, 2012
International publication of the international search report
Jun 18, 2012
Written opinion of the ISA, boxes No. I to VIII
Jun 18, 2012
Written opinion of the ISA, cover sheet
Jun 18, 2012
Written opinion of the ISA, supplemental box
May 3, 2012
Submission concerning representation
Apr 12, 2012
Priority document (electronically transmitted)
Apr 12, 2012
Priority document (electronically transmitted)
Mar 15, 2012
Published international application - A2
Sep 5, 2011
(Electronic) Receipt
Sep 5, 2011
Abstract
Sep 5, 2011
Claims
Sep 5, 2011
Description
Sep 5, 2011
Drawings
Sep 5, 2011
Priority document (RO-procedure)
Sep 5, 2011
Priority document (RO-procedure)

EP2613772

BAYER

Application Number: EP11757811A
Filing Date: Sep 5, 2011
Status: Revoked; Oct 12, 2018
Publication Date: Dec 14, 2016
External Links: Slate, Register , Google Patents

IP Verse

Low-Dose Transdermal Patches With High Drug Release

Patent Summary

Patent Family

Patent Oppositions

Dossier Documents

EP2613772